Boron: New Study and Diet Warning

#1

Boron is getting some love from Mic the Vegan. Looks over some studies, seems a pretty good idea to up your boron intake. Special note for kidney transplants (@LaraPo). FWIW, I’ve been supplementing with daily 3mg boron for ages, but since my surgery, I upped it to 6mg/day for bone health and wound healing.

Boron: New Vegan Study and Carnivore Diet Warning (via Mic the Vegan)

1 Like
#2

I. Executive Summary

This presentation evaluates dietary boron, framing it as an underappreciated ultratrace element enriched in whole plant foods and virtually absent in animal muscle meat. The central premise revolves around a cross-sectional study by Stübing et al. (2026) from the University of Freiburg, which evaluated 24-hour weighted dietary records and creatinine-corrected urinary excretion across omnivores, lacto-ovo-vegetarians, and vegans. The study demonstrated that vegans exhibit statistically significant elevations in creatinine-corrected urinary boron excretion compared to omnivores (approximately 1,559 µg/g vs. 919 µg/g creatinine, representing a ~70% delta), despite a non-statistically significant 26% difference in calculated intake. The presenter posits that unmeasured whole-food plant matrices account for this intake-to-excretion discrepancy and argues that strict carnivore or animal-only regimens risk chronic ultratrace boron depletion.

Extrapolating from this nutritional baseline, the narrative links boron status to broad clinical endpoints: all-cause mortality reduction in renal transplant recipients (Kremer et al., 2022), inverse epidemiological correlations with prostate cancer (Cui et al., 2004) and lung cancer (Mahabir et al., 2008), suppression of systemic inflammation, modulation of steroidogenesis (estradiol and free testosterone), bone mineralization via calcium retention (Nielsen et al., 1987), and enzymatic preservation of NAD+ pools via cyclic ADP-ribose hydrolase inhibition.

Critical translational appraisal reveals significant evidentiary heterogeneity. While boron is physiologically active as an ultratrace element, definitive human essentiality remains unestablished by regulatory bodies (e.g., European Food Safety Authority [EFSA], Institute of Medicine [IOM], World Health Organization [WHO]). Many attributed systemic benefits in human observational cohorts reflect broad dietary patterns—specifically, high fruit, vegetable, legume, and nut intake—introducing residual confounding where urinary boron acts primarily as an objective biomarker of plant consumption rather than an isolated therapeutic driver. Interventional trials utilizing supraphysiological supplementation (3–10 mg/day) show acute modulation of inflammatory biomarkers and transient endocrine alterations, but long-term randomized clinical trial (RCT) evidence confirming hard disease prevention remains sparse.

II. Insight Bullets

  • Boron is atomic element 5, recognized by global health authorities like the World Health Organization (WHO) and the National Institutes of Health (NIH) as an ultratrace nutrient without formally established dietary essentiality or Recommended Dietary Allowances (RDA).
  • Typical daily human dietary boron intake ranges between 1 mg and 3 mg, derived almost exclusively from plant-derived agricultural products.
  • Mammalian physiology does not bioaccumulate boron in skeletal muscle tissue; dietary exposure from animal meats and organ capsule products is virtually negligible.
  • Strict carnivore, “meat and water,” or zero-carbohydrate dietary paradigms lack standard dietary sources of boron, predisposing adherent individuals to ultratrace nutrient depletion.
  • The primary plant food sources richest in dietary boron include avocados, nut butters (almond and hazelnut), dried fruits (raisins and dried apricots), and legumes (red kidney beans, lentils, and chickpeas).
  • A cross-sectional investigation by Stübing et al. (2026) at the University of Freiburg evaluated boron status in healthy omnivores, vegetarians, and vegans using 24-hour weighed dietary logs calibrated to 0.1 g accuracy.
  • Dietary intake estimation in nutritional epidemiology frequently relies on fragmented national food composition tables (such as the USDA database), which systematically undercount trace mineral variations across plant cultivars.
  • Calculated median dietary boron intake in the Freiburg cohort showed non-statistically significant variance between vegans (~2.0 mg/day) and omnivores (~1.5 mg/day).
  • Creatinine-adjusted 24-hour urinary boron excretion in the Freiburg cohort was statistically significantly higher in vegans (~1,559 µg/g creatinine) than in omnivores (~919 µg/g creatinine), a ~70% differential.
  • Serum boron concentrations are homeostatically controlled via rapid renal clearance mechanisms, rendering 24-hour urinary excretion the primary validated biomarker of recent dietary exposure.
  • In renal transplant recipients, an observational cohort by Kremer et al. (2022) established an inverse association between urinary boron excretion and all-cause post-transplantation mortality.
  • Epidemiological datasets from the National Health and Nutrition Examination Survey (NHANES) documented an inverse relationship between calculated dietary boron intake and incident prostate cancer risk (Cui et al., 2004).
  • A case-control study by Mahabir et al. (2008) identified an inverse relationship between dietary boron exposure and lung cancer risk among postmenopausal women, with the highest intake quartile showing a significant risk decrement relative to the lowest.
  • Preclinical cell and animal models indicate that boron downregulates prostate-specific antigen (PSA) activity and inhibits cancer cell invasion and metastasis pathways in vitro (Barranco et al., 2007).
  • In vitro and in vivo studies suggest boron compounds induce apoptosis in malignant cell lines, though concentrations evaluated generally exceed physiological circulating serum concentrations.
  • Human depletion trials conducted at ~0.25 mg/day boron intake showed significant alterations in electroencephalogram (EEG) spectral frequencies, reflecting patterns associated with decreased central nervous system activation.
  • Severe dietary boron deprivation negatively affects human cognitive performance parameters, specifically motor speed, manual dexterity, eye-hand coordination, and short-term memory consolidation.
  • A pilot randomized, double-blind clinical trial by Hassanalilou et al. (2022) reported that 10 mg/day elemental boron supplementation (administered as boron citrate) improved clinical oxygen saturation, respiratory rate, and inflammatory indices in hospitalized COVID-19 patients.
  • In human nutritional studies by Nielsen et al. (1987), experimental dietary boron depletion in postmenopausal women provoked substantial reductions in plasma estradiol and total testosterone concentrations.
  • A triple-blind randomized clinical trial by Nikkhah et al. (2015) demonstrated that 10 mg/day boron supplementation significantly attenuated the pain score and duration of primary dysmenorrhea in nulliparous females compared to placebo.
  • Acute supraphysiological oral boron supplementation (6–10 mg/day) has been demonstrated to reduce circulating sex hormone-binding globulin (SHBG), thereby transiently increasing free unbound serum testosterone in adult males (Naghii et al., 2011).
  • Supplementation with 3 mg/day boron in postmenopausal women with low-boron diets reduced urinary calcium excretion by approximately 44%, illustrating a direct role in renal calcium conservation (Nielsen et al., 1987).
  • Clinical trials testing boron at 6 mg/day in populations with joint degeneration report functional symptom reduction and attenuation of pain scores in osteoarthritis (Travers et al., 1990).
  • Long-term bone mineral density intervention trials are fundamentally confounded because boron administration is almost universally paired with co-interventions such as calcium, cholecalciferol (vitamin D3), and magnesium.
  • Boron structurally binds cis-diol compounds, serving as a non-competitive physiological inhibitor of CD38 (cyclic ADP-ribose hydrolase), a major NAD±consuming glycoprotein implicated in age-associated NAD+ exhaustion.
  • Topical and systemic organoboron compounds demonstrate enhanced cutaneous wound healing dynamics and faster re-epithelialization kinetics in diabetic ulcer models by stimulating fibroblast proliferation and extracellular matrix deposition.

III. Actionable Protocol (Prioritized)

High Confidence Tier (Level A/B Evidence)

  • Dietary Boron Intake via Whole-Food Plant Matrices: Target an intake of 1.5–3.0 mg/day of elemental boron utilizing whole-food dietary sources. Consumption of 1/2 medium avocado (~0.8–1.0 mg), 2 tablespoons of almond butter (~0.8 mg), 1/4 cup of raisins (~1.1 mg), or 1 cup of cooked legumes (lentils, kidney beans, or chickpeas; ~0.5–1.0 mg) safely secures trace physiological intake without supplemental exposure.
  • Renal Calcium Retention & Skeletal Support: In populations vulnerable to osteopenia or elevated urinary mineral excretion, dietary optimization targeting ≥3 mg/day supports calcium and magnesium retention.
  • Primary Dysmenorrhea (Short-Term Protocol): Under clinical evaluation, elemental boron at 10 mg/day (e.g., sodium tetraborate or boron citrate) taken orally once daily for 5 days—initiated 2 days prior to menstrual onset and continued through day 3 of flow—demonstrates Level B efficacy for attenuating cramp severity and duration (Nikkhah et al., 2015).

Experimental Tier (Level C/D Evidence, High Safety Margins)

  • Transient Free Testosterone Optimization: Short-term, pulsed supplementation of 6–10 mg/day of elemental boron (as boron citrate or glycinate) for 1 to 2 weeks reduces SHBG and elevates free testosterone in men. *Caveat:*Long-term trials (>4 weeks) suggest compensatory homeostatic rebound, aromatization shifts toward estradiol, or return to endocrine baseline.
  • Osteoarthritis Symptom Management: Oral boron at 3–6 mg/day for 8–12 weeks exhibits moderate adjunctive anti-inflammatory properties (lowering hs-CRP, TNF-α) to ease joint discomfort.
  • Adjunctive Anti-Inflammatory / Respiratory Support: Low-dose supplementation (3–5 mg/day) as an adjunct in acute inflammatory pulmonary insults demonstrated preliminary biomarker improvements, but routine adoption requires confirmatory phase III validation.

Produced by Gemini 2.5 Pro

1 Like
#3

Most of the boron supplements tend not to be citrate or glycinate. I don’t think that matters, however.

I have been thinking about boron, however. I have been taking 3mg a day, but not on days when I fast (which can be 3 days a week). Hence I might either take 6mg a day or take it as part of my fasting supplement stack.